EVALUATION OF THE THERAPEUTIC SUPPORT POTENTIAL ON TYPE II DIABETES DISEASE CONTAINED IN Zingiber officinale Roscoe BY MOLECULAR DOCKING METHOD
About this article
Received: 24/09/23                Revised: 30/10/23                Published: 07/11/23Abstract
Keywords
Full Text:
PDF (Tiếng Việt)References
[1] T. H. Nguyen and T. H. T. Vu, "Plasma gama glutamyl transferase activity in diabetic patients," (in Vietnamese), TNU Journal of Science and Technology, vol. 226, no. 14, pp. 245-250, 2021.
[2] M. J. P. M. Cd, "Projections of global mortality and burden of disease from 2002 to 2030," PLoS Med vol. 3, pp. 2011-2030, 2006.
[3] N. H. Salleh, I. N. Zulkipli, H. Mohd Yasin, F. Ja’afar, N. Ahmad, W. A. N. Wan Ahmad, and S. R. Ahmad, "Systematic review of medicinal plants used for treatment of diabetes in human clinical trials: an ASEAN perspective," Evidence-based complementary and alternative medicine, vol. 2021, pp. 1-10, 2021.
[4] S. Skalli, R. Hassikou, and M. J. H. Arahou, "An ethnobotanical survey of medicinal plants used for diabetes treatment in Rabat, Morocco," Heliyon, vol. 5, no. 3, pp. 269-284, 2019.
[5] L. T. Ta, C. L. Tran, N. L. Pham, and T. X. T. Dai, "Effects of Lasia spinosa stem extract on enzyme glucose-6-phosphatase activity in the liver and kidneys of diabetic mice," (in Vietnamese), TNU Journal of Science and Technology, vol. 226, no. 10, pp. 47-54, 2021.
[6] G. S. El-Baroty, H. Abd El-Baky, R. Farag, and M. J. A. j. o. b. r. Saleh, "Characterization of antioxidant and antimicrobial compounds of cinnamon and ginger essential oils," African journal of biochemistry research vol. 4, no. 6, pp. 167-174, 2010.
[7] K. Jeena, V. B. Liju, and R. J. I. J. P. p. s. Kuttan, "Antitumor and cytotoxic activity of ginger essential oil (Zingiber officinale Roscoe)," Int J Pharm pharm sci vol. 7, no. 8, pp. 341-344, 2015.
[8] Y. Li, V. H. Tran, C. C. Duke, and B. D. Roufogalis, "Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review," (in Vietnamese), Evidence-Based Complementary and Alternative Medicine, vol. 2012, pp. 1-10, 2012.
[9] Y. Zhu, Y. Zhao, P. Wang, M. Ahmedna, and S. J. C. r. i. t. Sang, "Bioactive ginger constituents alleviate protein glycation by trapping methylglyoxal," Chemical research in toxicology vol. 28, no. 9, pp. 1842-1849, 2015.
[10] I. A. Guedes, C. S. de Magalhães, and L. E. J. B. r. Dardenne, "Receptor–ligand molecular docking," Biophysical reviews, vol. 6, pp. 75-87, 2014.
[11] U. Ilyas, B. Nazir, R. Altaf, Muhammad, H. Zafar, A. C. Paiva-Santos, and Y. Duan, "Investigation of anti-diabetic potential and molecular simulation studies of dihydropyrimidinone derivatives," Frontiers in Endocrinology, vol. 13, p. 1022623, 2022.
[12] D. Ahmed, M. I. Khan, G. Kaithwas, S. Roy, S. Gautam, M. Singh, and Saraf, "Molecular docking Analysis and Antidiabetic activity of Rifabutin against STZ-NA induced diabetes in albino wistar rats," Beni-Suef University journal of basic and applied sciences, vol. 6, no. 3, pp. 269-284, 2017.
[13] T. H. Nguyen, M. K. Trinh, T. H. S. Nguyen, and T. B. T. Nguyen, "Study on chemical composition and some of anti-microorganism activity of ginger essential oil (Zingiber officinale Roscoe) and black pepper essential oil (Piper nigrum L.)," (in Vietnamese), CTU Journal of Innovation and Sustainable Development, no. 21a, pp. 139-143, 2012.
[14] I. Sasidharan and A. N. J. I. J. o. C. P. R. Menon, "Comparative chemical composition and antimicrobial activity fresh & dry ginger oils (Zingiber officinale Roscoe)," International Journal of Current Pharmaceutical Research vol. 2, no. 4, pp. 40-43, 2010.
[15] K. E. Hevener, W. Zhao, D. M. Ball, K. Babaoglu, J. Qi, S. W. White, and R. E. Lee, "Validation of molecular docking programs for virtual screening against dihydropteroate synthase," Journal of chemical information and modeling, vol. 49, no. 2, pp. 444-460, 2009.
[16] H. N. Nguyen, T. T. H. Ta, K. L. Vu, and T. T. Bui, "Screening natural product compounds from Cleistocalyx operculatus for protein tyrosine phosphatase 1B inhibitory activity by using molecular docking method," (in Vietnamese), Journal of Medicine And Pharmacy, vol. 3, no. 11,pp. 94-104, 2021.
[17] A. Imran, M. T. Shehzad, S. J. A. Shah, M. Laws, T. Al-Adhami, K. M. Rahman, and J. Iqbal, "Development, molecular docking, and in silico ADME evaluation of selective ALR2 inhibitors for the treatment of diabetic complications via suppression of the polyol pathway," ACS omega, vol. 7, no. 30, pp. 26425-26436, 2022.
"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-ansi-language:PT-BR;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'>
DOI: https://doi.org/10.34238/tnu-jst.8814
Refbacks
- There are currently no refbacks.





